HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of surfactant phospholipids in lipid pneumonia induced with methylnaphthalene.

Abstract
Lipid analyses were carried out on the lungs of female B6C3F1 mice treated with methylnaphthalene. Cholesteryl ester, which could not be detected in lungs of control animals, was present in lungs of treated animals. Cholesterol and dipalmitoylglycerophosphocholine (DPPC) content was increased about five times in lungs of treated mice compared with control mice, and the content of a minor phospholipid was increased six times. The latter phospholipid was purified by high performance liquid chromatography and identified as phosphatidylglycerol by thin layer chromatography and by fast atom bombardment-mass spectrometry. Both DPPC and phosphatidylglycerol are known to be pneumonal surfactants produced from type II pneumocytes. Therefore, the accumulation of these lipids in lung tissue was assumed to be caused by the proliferation of type II cells induced by the administration of methylnaphthalene. The results provide important information concerning the underlying mechanism of endogenous lipid pneumonia in mice.
AuthorsT Taki, T Nakazima, Y Emi, Y Konishi, A Hayashi, M Matsumoto
JournalLipids (Lipids) Vol. 21 Issue 9 Pg. 548-52 (Sep 1986) ISSN: 0024-4201 [Print] United States
PMID3762327 (Publication Type: Journal Article)
Chemical References
  • Cholesterol Esters
  • Fatty Acids
  • Naphthalenes
  • Phospholipids
  • Pulmonary Surfactants
  • Triglycerides
  • Cholesterol
Topics
  • Animals
  • Cholesterol (metabolism)
  • Cholesterol Esters (metabolism)
  • Chromatography, Gas
  • Chromatography, High Pressure Liquid
  • Fatty Acids (analysis)
  • Female
  • Mass Spectrometry
  • Mice
  • Naphthalenes
  • Phospholipids (metabolism)
  • Pneumonia, Aspiration (metabolism)
  • Pneumonia, Lipid (chemically induced, metabolism)
  • Pulmonary Surfactants (metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: